{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:01:12Z","timestamp":1777935672683,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00296-012-2446-9","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T11:27:57Z","timestamp":1336649277000},"page":"733-741","source":"Crossref","is-referenced-by-count":17,"title":["Beh\u00e7et\u2019s disease: immunological relevance with arthritis of ankylosing spondylitis"],"prefix":"10.1007","volume":"33","author":[{"given":"Esin","family":"Aktas Cetin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulya","family":"Cosan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut Can","family":"Kucuksezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Bilgic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonca","family":"Cagatay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"key":"2446_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/31.5.299","volume":"31","author":"The International Study Group for Beh\u00e7et\u2019s Disease","year":"1992","unstructured":"The International Study Group for Beh\u00e7et\u2019s Disease (1992) Evaluation of diagnostic (\u2018classification\u2019) criteria in Beh\u00e7et\u2019s disease\u2014towards internationally agreed criteria. Br J Rheumatol 31:299\u2013308","journal-title":"Br J Rheumatol"},{"key":"2446_CR2","doi-asserted-by":"crossref","first-page":"681956","DOI":"10.1155\/2011\/681956","volume":"2011","author":"F Kaneko","year":"2011","unstructured":"Kaneko F, Togashi A, Saito S et al (2011) Beh\u00e7et\u2019s disease (Adamantiades-Beh\u00e7et\u2019s disease). Clin Dev Immunol 2011:681956","journal-title":"Clin Dev Immunol"},{"key":"2446_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-2249.1997.d01-947.x","volume":"107","author":"S Esin","year":"1997","unstructured":"Esin S, G\u00fcl A, Hodara V, Jeddi-Tehrani M, Dilsen N, Koni\u00e7e M, Andersson R, Wigzell H (1997) Peripheral blood T cell expansions in patients with Behcet\u2019s disease. Clin Exp Immunol 107:520\u2013527","journal-title":"Clin Exp Immunol"},{"key":"2446_CR4","first-page":"S16","volume":"28","author":"J Kim","year":"2010","unstructured":"Kim J, Park JA, Lee EY, Lee YJ, Song YW, Lee EB (2010) Imbalance of Th17 to Th1 cells in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 28:S16\u2013S19","journal-title":"Clin Exp Rheumatol"},{"key":"2446_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3129\/i07-179","volume":"43","author":"F Ilhan","year":"2008","unstructured":"Ilhan F, Demir T, T\u00fcrk\u00e7\u00fco\u011flu P, Turgut B, Demir N, G\u00f6dekmerdan A (2008) Th1 polarization of the immune response in uveitis in Beh\u00e7et\u2019s disease. Can J Ophthalmol 43:105\u2013108","journal-title":"Can J Ophthalmol"},{"key":"2446_CR6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","volume":"14","author":"NR Rose","year":"1993","unstructured":"Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited). Immunol Today 14:426\u2013430","journal-title":"Immunol Today"},{"key":"2446_CR7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123\u20131132","journal-title":"Nat Immunol"},{"key":"2446_CR8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10067-009-1205-0","volume":"28","author":"C Moll","year":"2009","unstructured":"Moll C, Bogas M, G\u00f3mez-Puerta JA et al (2009) Macroscopic features of knee synovitis in early untreated Beh\u00e7et disease and psoriatic arthritis. Clin Rheumatol 28:1053\u20131057","journal-title":"Clin Rheumatol"},{"key":"2446_CR9","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/ar2608","volume":"11","author":"JD Ca\u00f1ete","year":"2009","unstructured":"Ca\u00f1ete JD, Celis R, Noordenbos T et al (2009) Distinct synovial immunopathology in Beh\u00e7et disease and psoriatic arthritis. Arthritis Res Ther 11:R17","journal-title":"Arthritis Res Ther"},{"key":"2446_CR10","first-page":"S52","volume":"25","author":"M Amberger","year":"2007","unstructured":"Amberger M, Groll S, G\u00fcnaydin I, Deuter C, Vonthein R, K\u00f6tter I (2007) Intracellular cytokine patterns in Beh\u00e7et\u2019s disease in comparison to ankylosing spondylitis\u2013influence of treatment with interferon-alpha2a. Clin Exp Rheumatol 25:S52\u2013S57","journal-title":"Clin Exp Rheumatol"},{"key":"2446_CR11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03009740600905380","volume":"35","author":"AM Dalghous","year":"2006","unstructured":"Dalghous AM, Freysdottir J, Fortune F (2006) Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet\u2019s disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. Scand J Rheumatol 35:472\u2013475","journal-title":"Scand J Rheumatol"},{"key":"2446_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08916939209148460","volume":"12","author":"DG Charteris","year":"1992","unstructured":"Charteris DG, Barton K, McCartney AC, Lightman SL (1992) CD4+ lymphocyte involvement in ocular Beh\u00e7et\u2019s disease. Autoimmunity 12:201\u2013206","journal-title":"Autoimmunity"},{"key":"2446_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0923-1811(96)00588-9","volume":"15","author":"M Mochizuki","year":"1997","unstructured":"Mochizuki M, Morita E, Yamamoto S, Yamana S (1997) Characteristics of T cell lines established from skin lesions of Beh\u00e7et\u2019s disease. J Dermatol Sci 15:9\u201313","journal-title":"J Dermatol Sci"},{"key":"2446_CR14","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.1995.tb16946.x","volume":"132","author":"A G\u00fcl","year":"1995","unstructured":"G\u00fcl A, Esin S, Dilsen N, Koni\u00e7e M, Wigzell H, Biberfeld P (1995) Immunohistology of skin pathergy reaction in Beh\u00e7et\u2019s disease. Br J Dermatol 132:901\u2013907","journal-title":"Br J Dermatol"},{"key":"2446_CR15","first-page":"996","volume":"39","author":"N Sugi-Ikai","year":"1998","unstructured":"Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M (1998) Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Beh\u00e7et\u2019s disease. Invest Ophthalmol Vis Sci 39:996\u20131004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2446_CR16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163\u2013189","journal-title":"J Leukoc Biol"},{"key":"2446_CR17","doi-asserted-by":"crossref","unstructured":"Akdis M, Burgler S, Crameri R et al (2011) Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127(3):701-21.e1-70","DOI":"10.1016\/j.jaci.2010.11.050"},{"key":"2446_CR18","first-page":"329","volume":"25","author":"S Raziuddin","year":"1998","unstructured":"Raziuddin S, al-Dalaan A, Bahabri S, Siraj AK, al-Sedairy S (1998) Divergent cytokine production profile in Beh\u00e7et\u2019s disease. Altered Th1\/Th2 cell cytokine pattern. J Rheumatol 25:329\u2013333","journal-title":"J Rheumatol"},{"key":"2446_CR19","first-page":"321","volume":"23","author":"N Sayinalp","year":"1996","unstructured":"Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaro\u011flu IC, D\u00fcndar S, Kirazli S (1996) Cytokines in Beh\u00e7et\u2019s disease. J Rheumatol 23:321\u2013322","journal-title":"J Rheumatol"},{"key":"2446_CR20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H, T\u00fcrk\u00f6z Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et\u2019s disease. Mediators Inflamm 11:87\u201393","journal-title":"Mediators Inflamm"},{"key":"2446_CR21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1346-8138.1998.tb02372.x","volume":"25","author":"E Alpsoy","year":"1998","unstructured":"Alpsoy E, Cayirli C, Er H, Yilmaz E (1998) The levels of plasma interleukin-2 and soluble interleukin-2R in Beh\u00e7et\u2019s disease: a marker of disease activity. J Dermatol 25:513\u2013516","journal-title":"J Dermatol"},{"key":"2446_CR22","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/s100510170348","volume":"19","author":"I Ertenli","year":"2001","unstructured":"Ertenli I, Kiraz S, Calg\u00fcneri M et al (2001) Synovial fluid cytokine levels in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 19:S37\u2013S41","journal-title":"Clin Exp Rheumatol"},{"key":"2446_CR23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","volume":"30","author":"BC Aridogan","year":"2003","unstructured":"Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S (2003) Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Beh\u00e7et\u2019s disease. J Dermatol 30:602\u2013607","journal-title":"J Dermatol"},{"key":"2446_CR24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.intimp.2004.01.007","volume":"4","author":"ML Nagalakshmi","year":"2004","unstructured":"Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R (2004) Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 4:577\u2013592","journal-title":"Int Immunopharmacol"},{"key":"2446_CR25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","volume":"174","author":"R de Waal Malefyt","year":"1991","unstructured":"de Waal Malefyt R, Haanen J, Spits H et al (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915\u2013924","journal-title":"J Exp Med"},{"key":"2446_CR26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"N Mizuki","year":"2010","unstructured":"Mizuki N, Meguro A, Ota M et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et\u2019s disease susceptibility loci. Nat Genet 42:703\u2013706","journal-title":"Nat Genet"},{"key":"2446_CR27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet 42:698\u2013702","journal-title":"Nat Genet"},{"key":"2446_CR28","first-page":"391","volume":"72","author":"N Mukaida","year":"2000","unstructured":"Mukaida N (2000) Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72:391\u2013398","journal-title":"Int J Hematol"},{"key":"2446_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","volume":"48","author":"SP Durmazlar","year":"2009","unstructured":"Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A (2009) Significance of serum interleukin-8 levels in patients with Behcet\u2019s disease: high levels may indicate vascular involvement. Int J Dermatol 48:259\u2013264","journal-title":"Int J Dermatol"},{"key":"2446_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10067-003-0851-x","volume":"23","author":"L Freire Ade","year":"2004","unstructured":"Freire Ade L, Bertolo MB, de Pinho AJ, Samara AM Jr, Fernandes SR (2004) Increased serum levels of interleukin-8 in polyarteritis nodosa and Beh\u00e7et\u2019s disease. Clin Rheumatol 23:203\u2013205","journal-title":"Clin Rheumatol"},{"key":"2446_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s004030000128","volume":"292","author":"CC Zouboulis","year":"2000","unstructured":"Zouboulis CC, Katsantonis J, Ketteler R et al (2000) Adamantiades-Beh\u00e7et\u2019s disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279\u2013284","journal-title":"Arch Dermatol Res"},{"key":"2446_CR32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.immunol.17.1.331","volume":"17","author":"D Wallach","year":"1999","unstructured":"Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331\u2013367","journal-title":"Annu Rev Immunol"},{"key":"2446_CR33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","volume":"142","author":"JK Ahn","year":"2006","unstructured":"Ahn JK, Yu HG, Chung H, Park YG (2006) Intraocular cytokine environment in active Beh\u00e7et uveitis. Am J Ophthalmol 142:429\u2013434","journal-title":"Am J Ophthalmol"},{"key":"2446_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","volume":"30","author":"MO Oztas","year":"2005","unstructured":"Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B (2005) Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet\u2019s disease. Clin Exp Dermatol 30:61\u201363","journal-title":"Clin Exp Dermatol"},{"key":"2446_CR35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s00296-005-0040-0","volume":"26","author":"S Pay","year":"2006","unstructured":"Pay S, Erdem H, Pekel A et al (2006) Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Beh\u00e7et\u2019s disease. Does interleukin-1beta play a major role in Beh\u00e7et\u2019s synovitis? Rheumatol Int 26:608\u2013613","journal-title":"Rheumatol Int"},{"key":"2446_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/03009740701747137","volume":"37","author":"B Turan","year":"2008","unstructured":"Turan B, Pfister K, Diener PA et al (2008) Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Beh\u00e7et\u2019s disease. Scand J Rheumatol 37:135\u2013141","journal-title":"Scand J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2446-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2446-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T09:59:26Z","timestamp":1561715966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2446-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2446"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2446-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]}}}